In a shocking revelation, it has come to light that Pfizer's COVID-19 vaccine may not have undergone the rigorous testing it claimed before receiving emergency use authorization and subsequent approval from the U.S. Food and Drug Administration (FDA). This information has raised concerns about the safety and efficacy of the widely administered vaccine.
A closer examination of Pfizer's BNT162b2 trial, the basis for their COVID-19 vaccine, reveals a discrepancy between the compound used in the trial and the actual vials administered to individuals. The investigation conducted by Kevin McKernan, who gene-sequenced Pfizer's COVID injections, unveiled a troubling truth. The vaccine was found to be “wildly impure” and contained contaminants, including plasmids that acted as spike protein factories.
McKernan's discovery highlights the presence of various compounds that should not have been included in the final product. This finding contradicts the usual standards set by the FDA, which only allows certain generic, small-molecule drugs to be cloned based on bioequivalence for safety. Pfizer's COVID-19 vaccine is far from being categorized as a small-molecule generic drug.
According to Boriqua Gato, an expert in the field, Pfizer made a significant change in its manufacturing process, substituting a different drug for its trials than the one ultimately distributed worldwide. This substitution raises serious concerns about the validity of the testing conducted and implies fraudulent practices by the company. In simpler terms, it suggests that the vaccine administered to billions of people was never thoroughly tested.
These revelations cast doubt on the integrity of Pfizer's COVID-19 vaccine and raise questions about the extent to which regulatory bodies like the FDA scrutinize the drugs they approve. The implications of such a discovery are far-reaching, as millions of individuals have received this vaccine as a means to protect themselves and others from the coronavirus.
These claims are based on an investigation conducted by Kevin McKernan and the analysis of Boriqua Gato. As of now, there has been no official response from Pfizer or the FDA regarding these allegations.
